#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Endo names Joseph Ciaffoni as president, U.S. branded pharmaceuticals

Share on Twitter Share on LinkedIn
Staff Writer | Dublin, Ireland | August 9, 2016
EndoAugust 9, 2016, Dublin, Ireland - Endo International plc, a pharmaceutical company, announced the appointment of Joseph J. Ciaffoni as president, U.S. branded pharmaceuticals, effective August 15, 2016.
Prior to joining Endo, Mr. Ciaffoni served as Senior Vice President, Global Specialty Medicines Group for Biogen.

Mr. Ciaffoni started his employment with Biogen Idec in 2012 and during his tenure held senior roles including Senior Vice President, U.S. Commercial and Vice President, U.S. Neurology Field Operations and Marketing.

Prior to joining Biogen, Mr. Ciaffoni was Executive Vice President and Chief Operating Officer of Shionogi Inc. and President of Shionogi Pharmaceuticals.

Previously, he served as Vice President, Sales for Schering-Plough (now Merck) and held several commercial leadership roles at Sanofi-Synthelabo (now Sanofi) and Novartis.

Mr. Ciaffoni holds a B.A. in Communications and an M.B.A. from Rutgers, The State University of New Jersey.